CHAPEL HILL, N.C., Oct. 20 /PRNewswire/ -- With limited information on actual return on investment for expenditures toward support of Continuing Medical Education activities, pharmaceutical, biotechnology and medical device industry executives are anxious to understand the value of CME support and strategies for ensuring investments provide appropriate impact on healthcare practitioner behaviors and patient outcomes. In the recently published report by benchmarking firm, Best Practices, LLC, reviewing the CME support functions, benchmark respondents found significant opportunity for maximizing resources through centralization and innovative use of E-CME. Data from this study, "Educating the Market: Creating Value through Support of Continuing Medical Education," identified several key practices and metrics that can enable organizations to identify performance gaps and areas for improvement to better manage their CME support functions.
To view the study abstract or complimentary summary of the full report "Educating the Market: Creating Value through Support of Continuing Medical Education," click on the following link http://www3.best-in-class.com/rr971.htm .
In a benchmarking study that included such influential companies as
AstraZeneca, Bristol-Myers Squibb, Genentech, Johnson & Johnson, Merck,
Pfizer, Roche, Sanofi-Aventis and Wyeth, many key questions were covered,
-- What is the current landscape of continuing medical education (CME) in
North America and Europe?
-- What structural forms are used to deploy CME, optimize budgets & best
-- How rapidly is E-CME advancing?
-- What CME delivery channels are preferred?
-- What are the current trends and future directions of CME?
Among the key topics gathered in this report are:
-- Geographic delivery of CME
-- Structural manage
|SOURCE Best Practices, LLC|
Copyright©2008 PR Newswire.
All rights reserved